Catalyst Wire Dossier Catalyst Wire Dossier

mGlobal L+AS 20 mg/ml Hyaluronic Acid

Hyaluronic acid · Mesoestetic Pharma Group S.L.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mGlobal L+AS 20 mg/ml Hyaluronic Acid, covering 2024-07-01 to 2024-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds [NA]

See pricing